Gordon Reid PTC Therapeutics PTCT-Q TOP PICK Nov 23, 2011

Have come out with a new product line. Company has 20% growth target of earnings.

Gordon Reid

Owned

Unlock Rating

$19.010

Stock price when the opinion was issued

computer software

It's the ideal tool to help you make quicker, more informed decisions for managing and tracking your investments.

Get Signals Create your Watchlist

You might be interested:

PAST TOP PICK

(Top Pick Nov 23/11, Up 0.74%) Computer aided design area is down. Management is doing a good job. A good value stock and just needs some patience. This is a good entry point.

Most Recent Experts

Stockchase Insights

5i Research

John Ewing

Ewing Morris Investment Partners

The Panic-Proof Portfolio (Stockchase Research)

Stockchase Premium

Rebecca Teltscher

Newhaven Asset Management

Rick Rule

Rule Investment Media

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at : hello@stockchase.com.

Gordon Reid PTC Therapeutics PTCT-Q TOP PICK Nov 23, 2011

You might be interested:

PTC Therapeutics(PTCT-Q)

Latest Buy Signals

Today's Top Picks

Popular Articles

Latest Sell Signals